Back to Search
ANNE KUDELKA, MD
MD
Cardiovascular Disease Physician
NPI: 1376503557IndividualAccepts Medicare
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
036087780(IL)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
036087780(IL)
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
036087780(IL)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
RUSH MEDICAL COLLEGE OF RUSH UNIVERSITY
Class of 1991
Research & Publications (20)
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors.
PMID 18682950·Cancer Chemother Pharmacol·2009
3-trial
Optimal modeling for phase I design of a two drug combination-results of a phase I study of cisplatin with 9-nitrocamptothecin.
PMID 18600301·Invest New Drugs·2008
3-trial
Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis.
PMID 18221915·Lancet Oncol·2008
1-meta
The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer.
PMID 16242759·Gynecol Oncol·2006
8-other
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan.
PMID 14586557·Cancer Chemother Pharmacol·2004
3-trial
Physiological and psychological effects of delivering medical news using a simulated physician-patient scenario.
PMID 14593853·J Behav Med·2003
3-trial
Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor.
PMID 14625852·Proteomics·2003
8-other
Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.
PMID 13678723·Gynecol Oncol·2003
3-trial
Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.
PMID 12576458·Clin Cancer Res·2003
7-preclinical
Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
PMID 12473577·Clin Cancer Res·2002
3-trial
An in vitro study of inhibitory activity of gossypol, a cottonseed extract, in human carcinoma cell lines.
PMID 12457630·Pharmacol Res·2002
8-other
Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer.
PMID 12429628·Clin Cancer Res·2002
8-other
Induction of tumor-reactive CTL by C-side chain variants of the CTL epitope HER-2/neu protooncogene (369-377) selected by molecular modeling of the peptide: HLA-A2 complex.
PMID 12244144·J Immunol·2002
8-other
Radiation Therapy Oncology Group. Research Plan 2002-2006. Medical Oncology Committee.
PMID 11641021·Int J Radiat Oncol Biol Phys·2001
8-other
Malignant mixed mesodermal tumor of the ovary treated with a cisplatin-irinotecan combination: case report.
PMID 11766729·Eur J Gynaecol Oncol·2001
5-case
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix.
PMID 11745287·Cancer·2001
3-trial
Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy.
PMID 11742339·Surgery·2001
5-case
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group.
PMID 11641017·Int J Radiat Oncol Biol Phys·2001
8-other
Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir.
PMID 11360253·J Med Virol·2001
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 233 E ERIE ST, SUITE 305
CHICAGO, IL 60611 - Phone
- (312) 846-6641
Quick Facts
- NPI
- 1376503557
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile